| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6803df45466bf59035bebecacf234bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5047cfa30795494b1198494f1fe28ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d33a5fb70ceb11df20210c4249e3fe00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_decf944f8d1a9249b131f3204fcabafe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d90f799f10fc160ae7640486dae80410 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-40 |
| filingDate |
2009-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51ae6879344cbf71ee2ed8e4ef29d5bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64fe5941a133655d44a2fba3444c7122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8a933e992698e14f30841c3d8972699
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1697c8795bb32de92ed18f4297d8208 |
| publicationDate |
2010-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010032986-A3 |
| titleOfInvention |
Novel 5-(4-aminophenyl)-isoquinoline derivative, pharmaceutically acceptable salt thereof, production method for same, and composition containing same as active ingredient for prophylaxis and treatment of medical condition induced by raf kinase hyperactivity |
| abstract |
The present invention relates to a novel 5-(4-aminophenyl)-isoquinoline derivative or a pharmaceutically acceptable salt thereof, a production method for the same, and a composition containing the same as an active ingredient for the prophylaxis and treatment of a medical condition induced by the hyperactivity of Raf kinases. The composition containing a 5-(4-aminophenyl)-isoquinoline derivative according to the present invention effectively inhibits the activity of Raf kinases and particularly B-raf kinase, and thus can be used to good effect in the prophylaxis and treatment of such cancers or melanomas as are induced by the hyperactivity of Raf kinases. |
| priorityDate |
2008-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |